ScholarIQanswers from OpenAlex

Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats

PaperCitations, authors & open-access status

Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats have?

ScholarIQcitation count

Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats has 245 citations in the OpenAlex counts ScholarIQ stores.

When was Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats published?

ScholarIQyear

Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats has 2006 year in the ScholarIQ index.

What is the open-access status of Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats?

ScholarIQoa status

Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats has bronze oa status in the ScholarIQ index.

What is the DOI of Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats?

ScholarIQdoi

The DOI for Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats is on the source record.

What is the PMID of Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats?

ScholarIQpmid

The PMID for Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats is on the source record.

What is the OpenAlex record for Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats?

ScholarIQopenalex

The OpenAlex for Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial